Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,096.29
-0.6545-0.03%
Number of Gainers:440
Number of Losers:560
Number of Flat:21
PE:- -
High:2,100.64
Open:2,096.97
Low:2,093.04
Close:2,096.93
Volume:2.11B
Turnover:288.22B
Market Cap:97.51T
Float Cap:91.28T

Loading ...

VICI Properties Updates Financial Calendar for Third-Quarter Results Release and Earnings Call

Reuters
·
Sep 30

Honeywell Technologies Selected for About $300 Million Kenya Refinery Work

MT Newswires Live
·
Sep 30

Payoneer Global renews strategic partnership with Etsy

TIPRANKS
·
Sep 30

Dow to Showcase Pharmaceutical Innovations at CPHI Milan 2026

Reuters
·
Sep 30

Lilly Says Phase 3b ADtouch Trial Shows Ebglyss Beats Placebo in Hand and Foot Atopic Dermatitis Skin Clearance at Week 16

Reuters
·
Sep 30

Theriva Biologics Says Nature Medicine Publishes Virage Phase 2b Results for VCN-01 in Metastatic Pancreatic Cancer

Reuters
·
Sep 30

Jabil Posts Strong Earnings. the Stock Falls Anyway.

Dow Jones
·
Sep 30

Integer Says U.S. Antitrust Waiting Period Ends Early for KKR Deal at USD 127 a Share

Reuters
·
Sep 30

Trio Petroleum Acquires 24 Lloydminster Oil Wells for CDN$ 800,000, Transfers Water Disposal Asset to Marlin Resources

Reuters
·
Sep 30

DarkIris Sets up U.S. Subsidiary to Expand North America Operations

Reuters
·
Sep 30

Airbnb Adds AI Search, More Social Features - TechCrunch

Reuters
·
Sep 30

IBM Study Shows 62% of CFOs Take on Enterprise AI Strategy Leadership

Reuters
·
Sep 30

SEI Names Connall McGuckian Managing Director, Head of Singapore

Reuters
·
Sep 30

Rocket Doctor AI CEO Essam Hamza to Present at NIBA Investment Conference

Reuters
·
Sep 30

ISG Says Brazil Public Agencies Accelerate Digital Modernization Under Fiscal Pressure

Reuters
·
Sep 30

US Equity Futures Mostly Flat Pre-Bell as Traders Await Key Inflation Report

MT Newswires Live
·
Sep 30

Verrica Says Pooled Phase 3 Analysis Shows Ycanth Clears Molluscum About 4x Faster than Vehicle

Reuters
·
Sep 30

Eli Lilly - 77% of Ebglyss Patients Reported Satisfaction with Hand Clearance at Week 16

THOMSON REUTERS
·
Sep 30

Eli Lilly - Ebglyss Monotherapy Meets Primary and Secondary Endpoints at Week 16 in Phase 3B Adtouch Study

THOMSON REUTERS
·
Sep 30

New Phase 3B Data Show Lilly's Ebglyss (Lebrikizumab-Lbkz) Delivered Significant and Rapid Improvements in Skin Clearance, Itch, Pain, and Patient Satisfaction in People with Moderate-to-Severe Hand and Foot Atopic Dermatitis

THOMSON REUTERS
·
Sep 30